Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$29.00 – $29.00
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $143.41B | $140.99B | $114.51B | $120.19B | $128.33B | $141.71B | $156.01B | $163.49B |
| Cost of revenue | $54.73B | $53.39B | $45.34B | $50.13B | $55.63B | $62.73B | $64.81B | $67.10B |
| Gross profit | $88.68B | $87.60B | $69.17B | $70.07B | $72.70B | $78.97B | $91.20B | $96.40B |
| Gross margin | 61.8% | 62.1% | 60.4% | 58.3% | 56.7% | 55.7% | 58.5% | 59.0% |
| R&D | $13.03B | $10.50B | $10.77B | $10.61B | $9.79B | $8.61B | $0 | $0 |
| Operating income | $22.28B | $22.73B | $10.67B | $9.34B | $11.60B | $13.17B | $18.89B | $17.97B |
| EBITDA | $31.43B | $30.43B | $14.75B | $17.30B | $16.55B | $24.38B | $35.05B | $25.04B |
| Net income | $19.20B | $18.69B | $9.25B | $9.66B | $11.74B | $13.97B | $21.76B | $19.22B |
| Net margin | 13.4% | 13.3% | 8.1% | 8.0% | 9.1% | 9.9% | 13.9% | 11.8% |
| EPS (diluted) | 229.86 | 227.30 | 113.10 | 118.84 | 147.87 | 181.42 | 295.15 | 269.27 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $171.2B | $297.27 | $297.27–$297.27 | 1 |
| 2028 | $178.3B | $324.20 | $324.20–$324.20 | 1 |
| 2029 | $186.4B | $366.77 | $366.77–$366.77 | 1 |
| 2030 | $195.1B | $410.45 | $410.45–$410.45 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds HTSUF.
No tracked institution reports a position in HTSUF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-08-29 | $45.0000 | 2025-11-06 |
| 2025-08-29 | $15.0000 | 2025-11-06 |
| 2025-02-28 | $2.0000 | 2025-05-23 |
| 2025-02-28 | $43.0000 | 2025-05-23 |
| 2024-08-30 | $43.0000 | 2024-11-07 |
| 2024-08-30 | $2.0000 | 2024-11-07 |
| 2024-02-28 | $42.5000 | 2024-05-24 |
| 2023-08-30 | $42.5000 | 2023-11-07 |
No one on the platform has traded HTSUF yet.
| +0.00% |
| $3.8B |
| — |
| CURLFCuraleaf Holdings, Inc. | $9.99 | +3.74% | $2.6B | — |
| DMPHFDermapharm Holding SE | $53.00 | +0.00% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.